Adhesion to fibronectin selectively protects Bcr-Abl+ cells from DNA damage-induced apoptosis

被引:37
作者
van der Kuip, H
Goetz, AW
Miething, C
Duyster, J
Aulitzky, WE
机构
[1] Dr Margarete Fischer Bosch Inst Clin Pharmacol, Stuttgart, Germany
[2] Robert Bosch Krankenhaus, Dept Internal Med Oncol & Hematol, Stuttgart, Germany
[3] Tech Univ Munich, Dept Internal Med 3, D-8000 Munich, Germany
关键词
D O I
10.1182/blood.V98.5.1532
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The phenotype of Bcr-Abl-transformed cells is characterized by a growth factor-independent survival and a reduced susceptibility to apoptosis. Furthermore, Bcr-Abl kinase alters adhesion features by phosphorylating cytoskeletal and/or signaling proteins important for Integrin function. Integrin-mediated adhesion to extracellular matrix molecules Is critical for the regulation of growth and apoptosis. However, effects of Integrin signaling on regulation of apoptosis In cells expressing Bcr-Abl are largely unknown. The influence of adhesion on survival and apoptosis In Bcr-Abl(+) and Bcr-Abl(-) BaF3 cells was Investigated. p185bcr-abl-transfected BaF3 cells preadhered to immobilized fibronectin had a significant survival advantage and reduced susceptibility to apoptosis following gamma -irradiation when compared with the same cells grown on laminin, on polylysin, or in suspension. Both inhibition of Bcr-Abl kinase by ST1571 and Inhibition of specific adhesion reversed the fibronectin-mediated antiapoptotic effect In BaF3p185. The DNA damage response of Bcr-Abl- BaF3 cells was not affected by adhesion to fibronectin. In contrast to parental BaF3 cells, BaF3p185 adherent to fibronectin did not release cytochrome c to the cytosol following Irradiation. The fibronectin-mediated antiapoptotic mechanism In Bcr-Abl-active cells was not mediated by overexpression of Bcl-X-L or Bcl-2 but required an active phosphatidylinositol 3-kinase (PI-3K). Kinase-active Bcr-Abl in combination with fibronectin-induced integrin signaling led to a hyperphosphorylation of AKT. Thus, cooperative activation of PI-3K/AKT by Bcr-Abl and integrins causes synergistic protection of Bcr-Abr cells from DNA damage-induced apoptosis. (C) 2001 by The American Society of Hematology.
引用
收藏
页码:1532 / 1541
页数:10
相关论文
共 83 条
[1]   Bcr-Abl exerts its antiapoptotic effect against diverse apoptotic stimuli through blockage of mitochondrial release of cytochrome c and activation of caspase-3 [J].
Amarante-Mendes, GP ;
Kim, CN ;
Liu, L ;
Huang, Y ;
Perkins, CL ;
Green, DR ;
Bhalla, K .
BLOOD, 1998, 91 (05) :1700-1705
[2]   The SH2-containing adapter protein GRB10 interacts with BCR-ABL [J].
Bai, RY ;
Jahn, T ;
Schrem, S ;
Munzert, G ;
Weidner, KM ;
Wang, JYJ ;
Duyster, J .
ONCOGENE, 1998, 17 (08) :941-948
[3]   Nucleophosmin-anaplastic lymphoma kinase associated with anaplastic large-cell lymphoma activates the phosphatidylinositol 3-kinase/Akt antiapoptotic signaling pathway [J].
Bai, RY ;
Tao, OY ;
Miething, C ;
Morris, SW ;
Peschel, C ;
Duyster, J .
BLOOD, 2000, 96 (13) :4319-4327
[4]   Bcr/Abl expression stimulates integrin function in hematopoietic cell lines [J].
Bazzoni, G ;
Carlesso, N ;
Griffin, JD ;
Hemler, ME .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 98 (02) :521-528
[5]  
BEDI A, 1994, BLOOD, V83, P2038
[6]   BCR-ABL-MEDIATED INHIBITION OF APOPTOSIS WITH DELAY OF G2/M TRANSITION AFTER DNA-DAMAGE - A MECHANISM OF RESISTANCE TO MULTIPLE ANTICANCER AGENTS [J].
BEDI, A ;
BARBER, JP ;
BEDI, GC ;
ELDEIRY, WS ;
SIDRANSKY, D ;
VALA, MS ;
AKHTAR, AJ ;
HILTON, J ;
JONES, RJ .
BLOOD, 1995, 86 (03) :1148-1158
[7]   Apoptosis induced by erythroid differentiation of human leukemia cell lines is inhibited by Bcl-X(L) [J].
Benito, A ;
Silva, M ;
Grillot, D ;
Nunez, G ;
FernandezLuna, JL .
BLOOD, 1996, 87 (09) :3837-3843
[8]   Role of abnormal integrin-cytoskeletal interactions in impaired β1 integrin function in chronic myelogenous leukemia hematopoietic progenitors [J].
Bhatia, R ;
Munthe, HA ;
Verfaillie, CM .
EXPERIMENTAL HEMATOLOGY, 1999, 27 (09) :1384-1396
[9]   Interferon-alpha restores normal beta 1 integrin-mediated inhibition of hematopoietic progenitor proliferation by the marrow microenvironment in chronic myelogenous leukemia [J].
Bhatia, R ;
McCarthy, JB ;
Verfaillie, CM .
BLOOD, 1996, 87 (09) :3883-3891
[10]   Extracellular matrix and integrin signalling: the shape of things to come [J].
Boudreau, J ;
Jones, PL .
BIOCHEMICAL JOURNAL, 1999, 339 :481-488